MedTrace Logo

Assessing Parental Acceptance to Silver Diamine Fluoride Staining Before and After Masking the Colour With Glass Ionomer

NCT04509232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2021-09-27

No results posted yet for this study

Summary

Assessing Parents acceptance for the colour of Silver Diamine Fluoride on their Children anterior and posterior teeth before and after masking its colour with Glass Ionomer.

Conditions

  • Caries Arrested

Interventions

PROCEDURE

Silver diamine fluoride

Group A * Excavation of soft carious dentin will be done to minimize the staining. * The selected teeth should be cleaned, dried and isolated. Vaselline should be applied to surrounding soft tissues to avoid their staining.- * 38% Silver diamine fluoride will be applied to carious lesions by microbrush * Apply gentle flow of air until medicament is dry, Try to keep isolated for three minutes,remove excess SDF with cotton pellet to decrease systemic absorption. After silver diamine fluoride application Assessement of parental acceptance to staining will be done though a 5 point likert scale For anterior and posterior teeth separately .

PROCEDURE

Silver diamine fluoride and glass ionomer

* 38% Silver diamine fluoride will be applied by the same protocol as in group A Then Glass Ionomer restoration is applied * Parental acceptance to staining will be assessed thought 5 point likert scale after application of SDF and once more after application of Glass Ionomer restoration.

Sponsors & Collaborators

  • Dina Bassam Mohamed Ahmed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-12
Primary Completion
2021-07-22
Completion
2021-09-22

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04509232 on ClinicalTrials.gov